Tachykinin NK1 receptor antagonists for the control of chemotherapy-induced nausea and vomiting

Author： Gale Jeremy D O’Neill Brian T Humphrey John M

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.11, Iss.12, 2001-12, pp. : 1837-1847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Acupuncture in the Control of Chemotherapy-Induced Nausea and Vomiting

By Bao Ting

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 5, 2009-05 ,pp. : 606-612

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

5-HT Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Comparison of Their Pharmacology and Clinical Efficacy

By Gregory R.E. Ettinger D.S.

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 173-189

Adis International

Access to resources Recommend Favorite

Palonosetron for chemotherapy-induced nausea and vomiting

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

By Navari Rudolph M

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1977-1985

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting costly in Germany

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite